Patent · US Expired

Topical administration of amifostine and related compounds

US6753323B2 · kind B2 · utility

1Cited by
6References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 28, 2001
Grant dateJun 22, 2004
Priority date
Expiry dateAug 29, 2021

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P17/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is directed to methods of treating or protecting mucosal tissue from damage associated with radiation and/or chemotherapeutic treatment of cancers, by the topical application of amifostine and related compounds. These methods avoid the side effects of systemically applied radio/chemo protectants. The invention is also directed to treatment and prevention of infections associated with mucositis by topical application of amifostine and related compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.